Taysha Gene Therapies, Inc.
TSHA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001806310
In the last 90 days, Taysha Gene Therapies, Inc. insiders filed 0 open-market purchases and 1 sale; 208 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Taysha Gene Therapies, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 48 | 65 | +17 |
| Shares | 19.4M | 18.5M | −933.4K (−4.8%) |
| Value | $361.9M | $215.6M | −$146.3M (−40.4%) |
New holders (22)
Institutions that held Taysha Gene Therapies, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Quantum Private Wealth, LLC | 145,718 | $1.70M | 0.64% |
| Two Sigma Investments, LP | 69,229 | $807.0K | 0.00% |
| Millennium Management LLC | 60,049 | $700.0K | 0.00% |
| Marshall Wace, LLP | 58,358 | $679.0K | 0.00% |
| Gsa Capital Partners LLP | 40,885 | $476.0K | 0.06% |
| Citadel Advisors LLC | 36,337 | $423.0K | 0.00% |
| Two Sigma Advisers, LP | 34,100 | $397.0K | 0.00% |
| Trexquant Investment LP | 29,631 | $345.0K | 0.02% |
| Squarepoint Ops LLC | 29,210 | $340.0K | 0.00% |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 21,834 | $259.0K | 0.00% |
| Jump Financial, LLC | 20,700 | $241.0K | 0.02% |
| Cubist Systematic Strategies, LLC | 19,635 | $229.0K | 0.00% |
| ProShare Advisors LLC | 10,368 | $121.0K | 0.00% |
| 683 Capital Management, LLC | 10,000 | $117.0K | 0.01% |
| Wells Fargo & Company | 9,459 | $110.0K | 0.00% |
| Ensign Peak Advisors, Inc | 1,410 | $16.0K | 0.00% |
| Simplex Trading, LLC | 902 | $10.0K | 0.00% |
| US Bancorp | 524 | $6.00K | 0.00% |
| Quantbot Technologies LP | 514 | $5.00K | 0.00% |
| Daiwa Securities Group Inc. | 112 | $1.00K | 0.00% |
| Parallel Advisors, LLC | 45 | $1.00K | 0.00% |
| CWM, LLC | 25 | $0 | 0.00% |
Sold out (5)
Institutions that held Taysha Gene Therapies, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Perceptive Advisors LLC | 320,440 | $5.97M |
| Granite Point Capital Management, L.P. | 40,000 | $745.0K |
| Gilder Gagnon Howe & Co LLC | 37,578 | $700.0K |
| SG Americas Securities, LLC | 9,168 | $171.0K |
| Brewin Dolphin Ltd | 250 | $4.66K |